ID

41242

Description

MESA Treatment for NK/T Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01933282

Link

https://clinicaltrials.gov/show/NCT01933282

Keywords

Versions (1)
  1. 7/23/20 7/23/20 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

July 23, 2020

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Lymphoma, Extranodal NK-T-Cell NCT01933282

English

Eligibility Lymphoma, Extranodal NK-T-Cell NCT01933282

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
pathological diagnosis is nk/t cell lymphoma；
Description

Lymphoma, Extranodal NK-T-Cell

Data type

boolean

Alias
UMLS CUI [1]
C1955906
at least one objective evaluation ( measurable ) lesions
Description

Measurable lesion Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1265611
age 15 ~ 60 years old, men and women are not limited
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
ecog(eastern cooperative oncology group）performance status 0~3，expected to survive more than 3 months;
Description

ECOG performance status | Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C1520224
UMLS CUI [2]
C0023671
heart, kidney function in the normal range
Description

Cardiac function | Renal function

Data type

boolean

Alias
UMLS CUI [1]
C0232164
UMLS CUI [2]
C0232804
liver function: transminase< 2 times the normal value
Description

Liver function | Transaminases Measurement

Data type

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2,1]
C0002594
UMLS CUI [2,2]
C0242485
pregnancy tests of women childbearing age must be negative; men and women agree to use effective contraception during the treatment and the following year
Description

Childbearing Potential Pregnancy test negative | Agreement Contraceptive methods

Data type

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0427780
UMLS CUI [2,1]
C0680240
UMLS CUI [2,2]
C0700589
before the test sign the written informed consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
the early use of methotrexate or/and l-asparaginase;
Description

methotrexate | asparaginase

Data type

boolean

Alias
UMLS CUI [1]
C0025677
UMLS CUI [2]
C0003993
pregnant or nursing, psychiatric patients complicated with malignant tumor
Description

Pregnancy | Breast Feeding | Mental disorder Complicated Malignant Neoplasms

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C0004936
UMLS CUI [3,2]
C0231242
UMLS CUI [3,3]
C0006826
at the same time the application of other trial drug, drug contraindications exist in research;
Description

Investigational New Drugs | Pharmaceutical Preparations Contraindicated Research

Data type

boolean

Alias
UMLS CUI [1]
C0013230
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C1444657
UMLS CUI [2,3]
C0035168
serious infection or metabolic diseases
Description

Communicable Disease Serious | Metabolic Diseases

Data type

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205404
UMLS CUI [2]
C0025517
liver dysfunction, serum direct bilirubin, indirect bilirubin, transaminase 2 times higher than normal; serum total protein or albumin below normal;
Description

Liver Dysfunction | Direct bilirubin increased | Bilirubin unconjugated increased | Transaminases increased | Serum total protein decreased | Albumin measurement

Data type

boolean

Alias
UMLS CUI [1]
C0086565
UMLS CUI [2]
C0740434
UMLS CUI [3]
C0740435
UMLS CUI [4]
C0438717
UMLS CUI [5]
C0860703
UMLS CUI [6]
C0201838
renal insufficiency, creatinine clearance rate was 2 times higher than normal, especially the creatinine clearance rate is less than 30ml/min;
Description

Renal Insufficiency | Creatinine renal clearance increased

Data type

boolean

Alias
UMLS CUI [1]
C1565489
UMLS CUI [2]
C0919713
before entering the group, blood: white blood cell< 3×10e9/l; absolute neutrophil count<1.5×10e9/l; platelet<100×10e9/l ( bone marrow is not violated ); platelet count <75×10e9/l ( bone marrow invasion ); hemoglobin<100g/l.
Description

White Blood Cell Count procedure | Absolute neutrophil count | Platelet Count measurement | Bone Marrow Invasion | Hemoglobin measurement

Data type

boolean

Alias
UMLS CUI [1]
C0023508
UMLS CUI [2]
C0948762
UMLS CUI [3]
C0032181
UMLS CUI [4,1]
C0005953
UMLS CUI [4,2]
C1269955
UMLS CUI [5]
C0518015
in the 6 months before entering the group, patients with uncontrolled or serious cardiovascular diseases, including myocardial infarction, iii-iv class heart failure, uncontrolled angina or clinically significant pericardial disease, and diabetes and phlebitis;
Description

Cardiovascular Disease Uncontrolled | Cardiovascular Disease Serious | Myocardial Infarction | Heart failure New York Heart Association Classification | Angina Pectoris Uncontrolled | Disorder of pericardium | Diabetes Mellitus | Phlebitis

Data type

boolean

Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0007222
UMLS CUI [2,2]
C0205404
UMLS CUI [3]
C0027051
UMLS CUI [4,1]
C0018801
UMLS CUI [4,2]
C1275491
UMLS CUI [5,1]
C0002962
UMLS CUI [5,2]
C0205318
UMLS CUI [6]
C0265122
UMLS CUI [7]
C0011849
UMLS CUI [8]
C0031542
hiv antibody positive, hbsag positive after antiviral hbv(hepatitis b virus) dna titer in 104copies/ml the following groups. hiv antibody positive, hbsag+ and dna titer in 104copies/ml after antiviral hbv therapy
Description

HIV antibody positive | Hepatitis B surface antigen positive | Other Coding

Data type

boolean

Alias
UMLS CUI [1]
C0920548
UMLS CUI [2]
C0149709
UMLS CUI [3]
C3846158
coagulation abnormalities.
Description

Abnormality of coagulation

Data type

boolean

Alias
UMLS CUI [1]
C1846821
Back to the top of the page

Similar models

Eligibility Lymphoma, Extranodal NK-T-Cell NCT01933282

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Lymphoma, Extranodal NK-T-Cell
Item
pathological diagnosis is nk/t cell lymphoma；
boolean
C1955906 (UMLS CUI [1])
Measurable lesion Quantity
Item
at least one objective evaluation ( measurable ) lesions
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Age
Item
age 15 ~ 60 years old, men and women are not limited
boolean
C0001779 (UMLS CUI [1])
ECOG performance status | Life Expectancy
Item
ecog(eastern cooperative oncology group）performance status 0~3，expected to survive more than 3 months;
boolean
C1520224 (UMLS CUI [1])
C0023671 (UMLS CUI [2])
Cardiac function | Renal function
Item
heart, kidney function in the normal range
boolean
C0232164 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
Liver function | Transaminases Measurement
Item
liver function: transminase< 2 times the normal value
boolean
C0232741 (UMLS CUI [1])
C0002594 (UMLS CUI [2,1])
C0242485 (UMLS CUI [2,2])
Childbearing Potential Pregnancy test negative | Agreement Contraceptive methods
Item
pregnancy tests of women childbearing age must be negative; men and women agree to use effective contraception during the treatment and the following year
boolean
C3831118 (UMLS CUI [1,1])
C0427780 (UMLS CUI [1,2])
C0680240 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
Informed Consent
Item
before the test sign the written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
methotrexate | asparaginase
Item
the early use of methotrexate or/and l-asparaginase;
boolean
C0025677 (UMLS CUI [1])
C0003993 (UMLS CUI [2])
Pregnancy | Breast Feeding | Mental disorder Complicated Malignant Neoplasms
Item
pregnant or nursing, psychiatric patients complicated with malignant tumor
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0004936 (UMLS CUI [3,1])
C0231242 (UMLS CUI [3,2])
C0006826 (UMLS CUI [3,3])
Investigational New Drugs | Pharmaceutical Preparations Contraindicated Research
Item
at the same time the application of other trial drug, drug contraindications exist in research;
boolean
C0013230 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C1444657 (UMLS CUI [2,2])
C0035168 (UMLS CUI [2,3])
Communicable Disease Serious | Metabolic Diseases
Item
serious infection or metabolic diseases
boolean
C0009450 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0025517 (UMLS CUI [2])
Liver Dysfunction | Direct bilirubin increased | Bilirubin unconjugated increased | Transaminases increased | Serum total protein decreased | Albumin measurement
Item
liver dysfunction, serum direct bilirubin, indirect bilirubin, transaminase 2 times higher than normal; serum total protein or albumin below normal;
boolean
C0086565 (UMLS CUI [1])
C0740434 (UMLS CUI [2])
C0740435 (UMLS CUI [3])
C0438717 (UMLS CUI [4])
C0860703 (UMLS CUI [5])
C0201838 (UMLS CUI [6])
Renal Insufficiency | Creatinine renal clearance increased
Item
renal insufficiency, creatinine clearance rate was 2 times higher than normal, especially the creatinine clearance rate is less than 30ml/min;
boolean
C1565489 (UMLS CUI [1])
C0919713 (UMLS CUI [2])
White Blood Cell Count procedure | Absolute neutrophil count | Platelet Count measurement | Bone Marrow Invasion | Hemoglobin measurement
Item
before entering the group, blood: white blood cell< 3×10e9/l; absolute neutrophil count<1.5×10e9/l; platelet<100×10e9/l ( bone marrow is not violated ); platelet count <75×10e9/l ( bone marrow invasion ); hemoglobin<100g/l.
boolean
C0023508 (UMLS CUI [1])
C0948762 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0005953 (UMLS CUI [4,1])
C1269955 (UMLS CUI [4,2])
C0518015 (UMLS CUI [5])
Cardiovascular Disease Uncontrolled | Cardiovascular Disease Serious | Myocardial Infarction | Heart failure New York Heart Association Classification | Angina Pectoris Uncontrolled | Disorder of pericardium | Diabetes Mellitus | Phlebitis
Item
in the 6 months before entering the group, patients with uncontrolled or serious cardiovascular diseases, including myocardial infarction, iii-iv class heart failure, uncontrolled angina or clinically significant pericardial disease, and diabetes and phlebitis;
boolean
C0007222 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0007222 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C0027051 (UMLS CUI [3])
C0018801 (UMLS CUI [4,1])
C1275491 (UMLS CUI [4,2])
C0002962 (UMLS CUI [5,1])
C0205318 (UMLS CUI [5,2])
C0265122 (UMLS CUI [6])
C0011849 (UMLS CUI [7])
C0031542 (UMLS CUI [8])
HIV antibody positive | Hepatitis B surface antigen positive | Other Coding
Item
hiv antibody positive, hbsag positive after antiviral hbv(hepatitis b virus) dna titer in 104copies/ml the following groups. hiv antibody positive, hbsag+ and dna titer in 104copies/ml after antiviral hbv therapy
boolean
C0920548 (UMLS CUI [1])
C0149709 (UMLS CUI [2])
C3846158 (UMLS CUI [3])
Abnormality of coagulation
Item
coagulation abnormalities.
boolean
C1846821 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial